PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

With huge patient dataset, AI accurately predicts treatment outcomes

New model compares drug effectiveness – without a clinical trial

2024-05-01
(Press-News.org) COLUMBUS, Ohio – Scientists have designed a new artificial intelligence model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease.

The model was front-loaded with de-identified data on millions of patients gleaned from health care claims information submitted by employers, health plans and hospitals – a foundation model strategy similar to that of generative AI tools like ChatGPT.

By pre-training the model on a huge cache of general data, researchers could then fine-tune the model with information concerning specific health conditions and treatments – in this case, focusing on stroke risk – to estimate the causal effect of each therapy and determine which therapy would work best based on individual patient characteristics.

The team from The Ohio State University reported today (May 1, 2024) in the journal Patterns that their model outperformed seven existing models and came up with the same treatment recommendations as four randomized clinical trials.

“No existing algorithm can do this work,” said senior author Ping Zhang, associate professor of computer science and engineering and biomedical informatics at Ohio State. “Quantitatively, our method increased performance by 7% to 8% over other methods. And the comparison showed other methods could infer similar results, but they can’t produce a result exactly like a randomized clinical trial. Our method can.”

Replacing gold standard clinical research is not the point – but researchers hope machine learning could help save time and money by putting clinical trials on a faster track and support the personalization of patient care.

“Our model could be an acceleratory module that could help first identify a small group of candidate drugs that are effective to treat a disease, allowing clinicians to conduct randomized clinical trials on a limited scale with just a few drugs,” said first author Ruoqi Liu, a computer science and engineering PhD student in Zhang’s lab.

The team dubbed the proposed framework CURE: CaUsal tReatment Effect estimation.

The beauty of a treatment effect estimation model pre-trained with massive amounts of unlabeled real-world data is its applicability to a multitude of diseases and drugs, Liu said.

“We can pre-train the model on large-scale datasets without limiting it to any treatments. Then we fine-tune the pre-trained model on task-specific small-scale datasets so that the model can adapt quickly to different downstream tasks,” she said.

Unlabeled data used to pre-train the model came from MarketScan Commercial Claims and Encounters from 2012-2017, providing 3 million patient cases, 9,435 medical codes (including 282 diagnosis codes) and 9,153 medication codes.

Two of Liu’s model-constructing techniques added to CURE’s power: filling in gaps in patient records by pairing patient information with biomedical knowledge graphs that represent biomedical concepts and relationships, and pre-training a deep synergized patient data-knowledge foundation model using medical claims and knowledge graphs at scale.

“We also proposed KG-TREAT, a knowledge-enhanced foundation model, to synergize the patient data with the knowledge graphs to have the model better understand the patient data,” said Liu, who was the first author of a March Proceedings of the AAAI Conference on Artificial Intelligence paper describing the knowledge graph work.

To come up with treatment effect estimates, the model considers pre-trained data overlapped with more specific information on medical conditions and therapies, and after further fine-tuning, predicts which patient outcomes would correspond to different treatments.

As part of comparing the model to other machine learning tools and validating it against clinical trial results, the study showed that the broad pre-training is the backbone of CURE’s effectiveness – and incorporation of knowledge graphs improved its performance further.

Zhang envisions a day – pending Food and Drug Administration approval of AI as a decision-support tool – when clinicians could use this type of algorithm, loaded with electronic health record data from tens of millions of people, to access an actual patient’s “digital twin” and let the model function as a treatment guide.

“This model is better than a crystal ball: Based on big data and foundation model AI, we can have reasonable confidence to be able to say what treatment strategy is better,” said Zhang, who leads the Artificial Intelligence in Medicine Lab and is a core faculty member in the Translational Data Analytics Institute at Ohio State. “We want to put physicians in the driver’s seat to see whether this is something that can be helpful for them when they’re making critical decisions.”

This research was funded by the National Institutes of Health. Pin-Yu Chen of IBM Research was a study co-author of CURE in Patterns. Lingfei Wu of Anytime AI was a study co-author of KG-TREAT in AAAI.

#

Contact: Ping Zhang, Zhang.10631@osu.edu

Written by Emily Caldwell, Caldwell.151@osu.edu; 614-292-8152

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Organ transplant drug may slow Alzheimer’s disease progression in individuals with seizures

2024-05-01
PHILADELPHIA— Protein imbalances that increase brain cell excitability may explain why individuals with Alzheimer’s disease (AD) who also experience seizures demonstrate more rapid cognitive decline than those who do not experience seizures. These imbalances may be present in the brains of individuals before the onset of AD symptoms.The new findings, from a research team at the University of Pennsylvania’s Perelman School of Medicine, are published this week in Brain. The team found ...

Ochsner Health hospitals and partners earn an ‘A’ Spring 2024 Hospital Safety Grade from the Leapfrog Group

2024-05-01
NEW ORLEANS, La. – Dedicated to excellence in patient safety, several Ochsner Health hospitals and partners throughout Louisiana and Mississippi have earned an “A” Hospital Safety Grade from The Leapfrog Group, a national nonprofit watchdog. Leapfrog assigns an “A,” “B,” “C,” “D” or “F” grade to general hospitals across the country based on over 30 measures of errors, accidents, injuries and infections as well as the systems hospitals ...

FathomVerse mobile game inspires a new wave of ocean exploration

FathomVerse mobile game inspires a new wave of ocean exploration
2024-05-01
A new mobile game launching today allows anyone with a smartphone or tablet to take part in ocean exploration and discovery. Welcome to FathomVerse. Now available for download on the App Store and Google Play, FathomVerse allows players to interact with real underwater images to improve the artificial intelligence that helps researchers study ocean life. The game combines immersive imagery, compelling gameplay, and cutting-edge science to inspire a new wave of ocean explorers. Scientists are collecting massive amounts of images and video to study marine life and assess ocean ...

A “cosmic glitch” in gravity

2024-05-01
A group of researchers at the University of Waterloo and the University of British Columbia have discovered a potential “cosmic glitch” in the universe’s gravity, explaining its strange behaviour on a cosmic scale.  For the last 100 years, physicists have relied upon Albert Einstein’s theory of “general relativity” to explain how gravity works throughout the universe. General relativity, proven accurate by countless tests and observations, suggests that gravity impacts ...

The women’s health initiative randomized trials and clinical practice

2024-05-01
About The Study: For postmenopausal women, the Women’s Health Initiative (WHI) randomized clinical trials do not support menopausal hormone therapy to prevent cardiovascular disease or other chronic diseases. Menopausal hormone therapy is appropriate to treat bothersome vasomotor symptoms among women in early menopause, without contraindications, who are interested in taking hormone therapy. The WHI evidence does not support routine supplementation with calcium plus vitamin D for menopausal women to prevent fractures or a low-fat diet with increased fruits, vegetables, and grains to prevent ...

Race and ethnicity of reproductive-age females affected by state abortion bans

2024-05-01
About The Study: The proportions of American Indian or Alaska Native, Black, and white females of reproductive age in states with effective abortion bans were higher than in states without such policies, while proportions for other racial and ethnic groups were lower. Although these restrictive laws were not based on race, they were concentrated in states with higher proportions of American Indian or Alaska Native and Black individuals, resulting in a differential effect of restrictive abortion laws in these groups. American Indian or Alaska Native and Black populations are disproportionately affected by disparities in pregnancy-related ...

Father’s gut microbes affect the next generation

Father’s gut microbes affect the next generation
2024-05-01
The gut microbiota is the microbial community that occupies the gastrointestinal tract. It is responsible for producing enzymes, metabolites, and other molecules crucial for host metabolism and in response to the environment. Consequently, a balanced gut microbiota is important for mammalian health in many ways, such as helping to regulate the immune and endocrine systems. This in turn, impacts the physiology of tissues throughout the body. However, little was known about the impact of the gut microbiota on host reproduction, ...

Scientists work out the effects of exercise at the cellular level

2024-05-01
The health benefits of exercise are well known but new research shows that the body’s response to exercise is more complex and far-reaching than previously thought. In a study on rats, a team of scientists from across the United States has found that physical activity causes many cellular and molecular changes in all 19 of the organs they studied in the animals. Exercise lowers the risk of many diseases, but scientists still don’t fully understand how exercise changes the body on a molecular level. Most studies have focused on a single organ, sex, or time point, and only include one or two data types.  To take a more comprehensive ...

CHOP researchers identify causal genetic variant linked to common childhood obesity

2024-05-01
Philadelphia, May 1, 2024 – Researchers from Children’s Hospital of Philadelphia (CHOP) have identified a causal genetic variant strongly associated with childhood obesity. The study provides new insight into the importance of the hypothalamus of the brain and its role in common childhood obesity and the target gene may serve as a druggable target for future therapeutic interventions. The findings were published today in the journal Cell Genomics. Both environmental and genetic factors play critical roles in the increasing incidence of childhood ...

UVM scientists decode exercise's molecular impact

UVM scientists decode exercises molecular impact
2024-05-01
BURLNGTON, Vt.—For the past eight years, researchers have been conducting a groundbreaking study supported by the National Institutes of Health (NIH) Common Fund: The Molecular Transducers of Physical Activity Consortium (MoTrPAC). With nearly 2,600 volunteers, the study aims to examine the molecular effects of exercise on healthy adults and children, considering factors like age, race, and gender. The goal is to create comprehensive molecular maps of these changes and uncover why physical activity has significant health benefits. “This ...

LAST 30 PRESS RELEASES:

Music-based therapy may improve depressive symptoms in people with dementia

No evidence that substituting NHS doctors with physician associates is necessarily safe

At-home brain speed tests bridge cognitive data gaps

CRF appoints Josep Rodés-Cabau, M.D., Ph.D., as editor-in-chief of structural heart: the journal of the heart team

Violent crime is indeed a root cause of migration, according to new study

Customized smartphone app shows promise in preventing further cognitive decline among older adults diagnosed with mild impairment

Impact of COVID-19 on education not going away, UM study finds

School of Public Health researchers receive National Academies grant to assess environmental conditions in two Houston neighborhoods

Three Speculum articles recognized with prizes

ACM A.M. Turing Award honors two researchers who led the development of cornerstone AI technology

Incarcerated people are disproportionately impacted by climate change, CU doctors say

ESA 2025 Graduate Student Policy Award Cohort Named

Insomnia, lack of sleep linked to high blood pressure in teens

Heart & stroke risks vary among Asian American, Native Hawaiian & Pacific Islander adults

Levels of select vitamins & minerals in pregnancy may be linked to lower midlife BP risk

Large study of dietary habits suggests more plant oils, less butter could lead to better health

Butter and plant-based oils intake and mortality

20% of butterflies in the U.S. have disappeared since 2000

Bacterial ‘jumping genes’ can target and control chromosome ends

Scientists identify genes that make humans and Labradors more likely to become obese

Early-life gut microbes may protect against diabetes, research in mice suggests

Study raises the possibility of a country without butterflies

Study reveals obesity gene in dogs that is relevant to human obesity studies

A rapid decline in US butterfly populations

Indigenous farming practices have shaped manioc’s genetic diversity for millennia

Controlling electrons in molecules at ultrafast timescales

Tropical forests in the Americas are struggling to keep pace with climate change

Brain mapping unlocks key Alzheimer’s insights

Clinical trial tests novel stem-cell treatment for Parkinson’s disease

Awareness of rocky mountain spotted fever saves lives

[Press-News.org] With huge patient dataset, AI accurately predicts treatment outcomes
New model compares drug effectiveness – without a clinical trial